FRANCISCO DE PAULA
TELLEZ PEREZ
Profesor asociado de Ciencias de la Salud
Hospital Universitario de la Princesa
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario de la Princesa (20)
2023
-
Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice
Journal of Antimicrobial Chemotherapy, Vol. 78, Núm. 10, pp. 2591-2596
2021
-
Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy
Journal of Viral Hepatitis, Vol. 28, Núm. 6, pp. 878-886
-
Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response
AIDS (London, England), Vol. 35, Núm. 13, pp. 2119-2127
-
Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 72, Núm. 5, pp. e96-e102
-
Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 9, pp. 2375-2379
2020
-
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
AIDS (London, England), Vol. 34, Núm. 10, pp. 1497-1507
-
Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 71, Núm. 9, pp. 2354-2362
2019
-
Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients
Journal of Viral Hepatitis, Vol. 26, Núm. 1, pp. 48-54
-
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks
Journal of Infection, Vol. 79, Núm. 1, pp. 30-35
-
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
AIDS, Vol. 33, Núm. 2, pp. 269-278
2018
-
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice
HIV Clinical Trials, Vol. 19, Núm. 1, pp. 23-30
2017
-
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study
HIV Clinical Trials, Vol. 18, Núm. 3, pp. 126-134
2016
2015
-
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 9, pp. 1879-1884
2013
-
Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis
Clinical Infectious Diseases, Vol. 56, Núm. 11, pp. 1646-1653
-
Short communication: Atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C
AIDS Research and Human Retroviruses, Vol. 29, Núm. 2, pp. 223-225
2012
-
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
AIDS, Vol. 26, Núm. 13, pp. 1721-1724
-
Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis
Clinical Infectious Diseases, Vol. 55, Núm. 12, pp. 1719-1726
2011
-
Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 6, pp. 1346-1350
2010
-
Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/ hepatitis C Virus-Coinfected patients
Journal of AIDS and Clinical Research, Vol. 1, Núm. 3